Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

26.14
-0.9800-3.61%
Volume:161.39K
Turnover:4.24M
Market Cap:777.17M
PE:-31.36
High:26.93
Open:26.81
Low:25.76
Close:27.12
52wk High:44.28
52wk Low:14.59
Shares:29.73M
Float Shares:25.11M
Volume Ratio:0.41
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8334
EPS(LYR):-0.8334
ROE:-5.21%
ROA:-2.56%
PB:1.65
PE(LYR):-31.36

Loading ...

Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report